Article info
Oesophagus
Original article
Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial
- Correspondence to Dr Nicholas J Shaheen, Center for Esophageal Diseases and Swallowing, University of North Carolina, CB 7080, Chapel Hill, NC 27599, USA; nshaheen{at}med.unc.edu
Citation
Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial
Publication history
- Revised May 23, 2012
- Accepted May 25, 2012
- First published June 23, 2012.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions